Drugs / recombinant M. tuberculosis vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00397943 Comparator | Nov 2006 → Dec 2009 | tuberculosis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant M. tuberculosis vaccine | “GSK Biologicals' candidate recombinant M. tuberculosis vaccine, non-adjuvanted, administered intramuscularly in the deltoid muscle of the non-dominant arm at Month 0 and Month 1.” NCT00397943 ↗ |
| Modality | Vaccine | “candidate recombinant M. tuberculosis vaccine” NCT00397943 ↗ |